Max India Limited is a holding company building an integrated senior care ecosystem in India, operating through three verticals: Antara Senior Living (residences), Antara Assisted Care (care homes and care at home), and AGEasy (senior-focused consumer products). The residences business uses an asset-light model—developing and then managing communities for long-term fees, with Dehradun already profitable (INR6.2 crore revenue in Q1 FY27, operating profit INR0.92 crore) and Gurgaon Estate 360 fully sold with INR556 crore collections and INR47.69 crore management fees earned through June 2026. Assisted care operates 485 beds across 8 care homes, with 5 of 8 trending as per the operating model and 4 homes achieving highest revenue per occupied bed of INR7,000+ in June 2026. AGEasy sells 112 senior-specific products, with gross margins of 45% on online channels and an annualized revenue run rate approaching INR120 crore. The competitive structure is favorable: Max India is the only listed integrated player, with care home competitors like Sukino and Athulya limited to the South, and no other player combining residences, care, and products. The current margin profile is negative at the consolidated level—Q1 FY27 EBITDA loss of INR25 crore on revenue of INR68.6 crore (up 66% YoY)—but the underlying units are improving: Dehradun is profitable, care home contribution margins are turning positive, and AGEasy is scaling with stable gross margins.
The economics persist because of multiple reinforcing barriers. In residences, the company's services IP and integrated wellness protocols create switching costs for residents; real estate developers typically outsource healthcare services, so Antara's operational expertise is not easily replicated. The care home business requires 8-10 quarters to reach maturity, and the company has secured NABH accreditation for two homes, setting a quality standard that new entrants must match. AGEasy's moat comes from patents—4 granted and 3 filed—including the only adult diaper with smart absorption technology, and a senior-specific product design that competitors lack. The asset-light residence model requires low capital intensity, with management fees of INR130 crore and INR200 crore expected from Estate 360 and 361 respectively over their project cycles. While the care home market is fragmented, the integrated ecosystem—where a resident can move from a residence to a care home and buy products from AGEasy—creates a unique value proposition that no competitor currently offers. The company's brand, with resident satisfaction scores above 85% and an under-4-minute emergency response time, further entrenches its position.
The inflection is now, with multiple triggers converging over the next 18-24 months. By mid-2028, the business should look fundamentally different. AGEasy is guided to be EBITDA positive by Q4 FY27 (by March 2027) and to double revenue to INR150+ crore in FY27, with an exit monthly run rate of INR14-16 crore. Care homes are expected to reach consolidated EBITDA breakeven in H1 FY28, with mature homes achieving 65-70% occupancy and 18-20% EBITDA margins; the company will decide on expanding beyond the current 485 beds in October-November 2026, and capital requirement is INR10-12 lakh per bed. The residences vertical is targeting 1.5 million sq ft per year, with Noida Phase 2 (440,000 sq ft) re-filing for approval in FY27 at sales prices 2-3 times higher than Phase 1 (which sold at INR7,000-11,000 per sq ft; current market rates are INR16,000-18,000+). Bangalore (300 units, potential sales value INR900 crore) and Dehradun expansion (less than 150 units, INR850-900 crore) are in advanced stages. By FY28, consolidated profitability is targeted, with revenue trajectory from Q1 FY27's INR68.6 crore scaling significantly as Noida Phase 1 possession unlocks INR150 crore in receivables and new projects generate management fees.
Management's walk-talk has been consistent across the last four calls. They promised AGEasy breakeven by Q4 FY27, care home EBITDA breakeven by H1 FY28, and consolidated profitability by FY28—these targets have been repeated without revision. They have delivered on several milestones: Estate 361 launched in December 2025 as planned, with 154 bookings by June 2026 and collections of INR108.2 crore; Noida Phase 1 possession was offered in June 2026, with 75% of dues collected; all 8 care homes are now operational after the DLF Phase 2 Gulmarg relaunch in July 2026. They raised INR124 crore via rights issue and INR80 crore via preferential warrants, with the second tranche of INR40 crore received in July 2026. However, they missed the 1.5 million sq ft residential target for FY26 due to the Chandigarh setback (height clearances), and the INR200-250 crore fundraise mentioned in February 2026 has not yet been executed, though the pref issue provides partial funding. Management has been transparent about delays, such as the Noida OC pending in Supreme Court, and has adjusted plans—pursuing Bangalore and Dehradun to catch up on the sq ft commitment.
The earnings path is quantified: AGEasy EBITDA positive by Q4 FY27, care homes breakeven in H1 FY28, and consolidated profitability by FY28. For this to hold, three things must be true: Noida Phase 2 approval and sales at 2-3x Phase 1 prices, care home occupancy reaching 50%+ on mature beds (currently 5 of 8 homes trending as per model), and AGEasy maintaining gross margins around 45% while shifting from 80% performance marketing to a 40:60 organic mix. The single most important watchpoint is Noida Phase 2 approval, as profits are largely dependent on it; the Bangalore project also depends on completing diligence with the developer. The tension in the latest quarter—EBITDA loss widened to INR25 crore from INR23.2 crore YoY despite 66% revenue growth—is operational, not structural: the company is investing in care home ramp-up and AGEasy marketing, while gross margins are stable and Q4 FY26 loss was only INR6.8 crore, indicating seasonality and investment timing. Geopolitical risks on AGEasy's 30% China sourcing and logistics costs are manageable but could pressure margins. If these milestones are met, Max India will be a profitable, integrated senior care leader with multiple revenue streams—management fees, annuity income, care home EBITDA, and product margins—by mid-2028.
companyname: Max India Limited ticker: MAXIND sector: Senior Care / Healthcare Services Max India Limited is the senior care arm of the $7-billion Max Group. It is a listed holding company, created in 2019 as Advaita Allied Health Services Limited and renamed Max India Limited in July 2020. It operates the brand Antara Senior Care through three subsidiaries: Antara Senior Living Limited (residences for seniors), Antara Purukul Senior Living Limited (the Dehradun flagship community), and Antara ...
Read the full report →margin expansion, new product segment, geographic expansion
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Max India Limited and 4,900+ companies.
5-day free pass. No card required.